Lead Speaker: Petra Denig, PharmD, PhD, FISPE – University Medical Center Groningen
Lead Speaker: Lotte Rasmussen, MScPharm, PhD – Syddansk Universitet
Speaker: Mina Tadrous, PharmD, PhD, MS, FISPE – University of Toronto
Speaker: Lisa G. Pont, PhD – Discipline of Pharmacy, University of Technology Sydney, Sydney, NSW, Australia
Speaker: Björn Wettermark, MscPharm, PhD (he/him/his) – Uppsala university
Moderator: Juan M. Hincapie-Castillo, PharmD, MS, PhD (he/him/his) – University of North Carolina at Chapel Hill
Moderator: Caitlin Knox, PhD MPH (she/her/hers) – Regeneron Pharmaceuticals, Inc.
Speaker: Vincent Lo Re, III, MD, MSCE (he/him/his) – Perelman School of Medicine at the University of Pennsylvania
Speaker: Mary Beth E. Ritchey, PhD, FISPE – Food and Drug Administration
Speaker: Robert W. Platt, PhD (he/him/his) – Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada
Lead Speaker: Amalia M. Issa, PhD, MPH, FISPE
Lead Speaker: Gillian Bartlett-Esquilant, PhD, FISPE – University of Missouri School of Medicine
Speaker: Stephen E. Kimmel, MD, MSCE, FISPE – University of Florida
Speaker: Anke-Hilse Maitland-van der Zee, PharmD, PhD (she/her/hers) – Amsterdam UMC
Speaker: Bruce C. Carleton, PharmD, FCP, FISPE – University of British Columbia
Lead Speaker: Natasha Pratt, PhD (she/her/hers) – U.S. Food and Drug Administration
Speaker: Christian Hampp, PhD, FISPE (he/him/his) – Regeneron Pharmaceuticals, Inc., Tarrytown, NY
Speaker: Jessica Jalbert, PhD (she/her/hers) – Regeneron
Speaker: Soko Setoguchi, MD, DrPH, FISPE – Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ
Speaker: Ximena Camacho, MMath (she/her/hers) – UNSW Sydney
Speaker: Hui-Lee Wong, PhD (she/her/hers) – US Food and Drug Administration
Speaker: Silvia Perez-Vilar, PhD, PharmD – US Food and Drug Administration
Speaker: Olivier Humblet
Lead Speaker: Tobias Gerhard, PhD, FISPE (he/him/his) – Center for Pharmacoepidemiology and Treatment Science, Rutgers University
Speaker: Almut G. Winterstein, PhD, FISPE – University of Florida, Pharmaceutical Outcomes & Policy, Center for Drug Evaluation & Safety
Speaker: Tania Schink, Dr, MPH (she/her/hers) – Leibniz Institute for Prevention Research and Epidemiology - BIPS
Lead Speaker: Danica Marinac-Dabic, MD, PhD, MMSc, FISPE (she/her/hers) – FDA/CDRH/ Office of Clinical Evidence and Analysis
Speaker: Katherine Donegan, PhD – Medicines and Healthcare products Regulatory Agency
Lead Speaker: Kevin Haynes, PharmD, MSCE (he/him/his) – Janssen Pharmaceuticals
Speaker: Rosa Gini, PhD (she/her/hers) – ARS Toscana, Florence, Italy
Speaker: Matthew Reynolds, PhD, FISPE – Flatiron Health
Speaker: Daniel C. Beachler, PhD, MHS (he/him/his) – Carelon Research
Speaker: Sudha R. Raman, PhD (she/her/hers) – Department of Population Health Sciences, Duke University School of Medicine, Durham, NC
Lead Speaker: Andrew Freedman, PhD, FISPE – DHHS/NIH/NICHD
Lead Speaker: Bruce C. Carleton, PharmD, FCP, FISPE – University of British Columbia
Speaker: Donna R. Rivera, PharmD, MSc, FISPE – Oncology Center of Excellence, US Food and Drug Administration
Speaker: Wei Zhou, MD, PhD, FISPE (he/him/his) – Eli Lilly and Company
Speaker: Geoffrey Liu, MSc, MD (he/him/his) – Princess Margaret Cancer Centre, University Health Network, Toronto, Canada
Lead Speaker: Michele Jonsson Funk, PhD, FISPE (she/her/hers) – UNC Chapel Hill Gillings School of Global Public Health
Speaker: Jennifer L. Lund, PhD, FISPE (she/her/hers) – Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill
Speaker: Sudha R. Raman, PhD (she/her/hers) – Department of Population Health Sciences, Duke University School of Medicine, Durham, NC
Speaker: Mugdha Gokhale, PhD – Pfizer
Speaker: Til Stürmer, MD, PhD (he/him/his) – Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill
Speaker: Jessica C. Young, PhD (she/her/hers) – Karolinska Institutet
Lead Speaker: Jennifer Christian, PharmD,PhD, FISPE (she/her/hers) – TargetRWE
Lead Speaker: Priscilla Velentgas, MS, PhD (she/her/hers) – Merck
Speaker: Cynthia J. Girman, DrPH FISPE – CERobs Consulting, LLC
Speaker: Anne Trontell, MPH, MD (she/her/hers) – Patient Centered Outcomes Research Institute
Speaker: Jay Park, PhD (he/him/his) – Core Clinical Sciences
Speaker: Kathleen E. Hurwitz, ScD (she/her/hers) – Target RWE
Lead Speaker: Jenny Sun, PhD – Pfizer, Inc.
Speaker: Tamar Lasky, PhD, FISPE (she/her/hers) – US FDA
Speaker: Daniel B. Horton, MD, MSCE, FISPE (he/him/his) – Department of Pediatrics, Rutgers Robert Wood Johnson Medical School; Rutgers University, New Brunswick, NJ, USA
Speaker: Mehmet Burcu, PhD, MS (he/him/his) – Merck & Co., Inc., Rahway, NJ, United States
Speaker: Ann W. McMahon, MD, MS, FISPE – Office of Pediatric Therapeutics
Lead Speaker: John D. Seeger, PharmD, DrPH, FISPE – Optum Epidemiology
Speaker: Jeremy A. Rassen, ScD, FISPE – Aetion
Lead Speaker: Emily W. Bratton, MSPH, PhD (she/her/hers) – IQVIA
Speaker: Laura Hester, PhD – Janssen R&D, LLC
Speaker: Xabier Garcia de Albeniz Martinez, MD, ScM, PhD – RTI Health Solutions
Speaker: Jie Li, PhD – US Food and Drug Administration
Lead Speaker: Katja Taxis, MSc, PhD, FISPE – University of Groningen
Speaker: Lisa G. Pont, PhD – Discipline of Pharmacy, University of Technology Sydney, Sydney, NSW, Australia
Speaker: Jennifer E. Isenor, BSc(Pharm), PharmD, RPh (she/her/hers) – College of Pharmacy, Dalhousie University
Lead Speaker: Alicia W. Gilsenan, PhD, RPh, FISPE – RTI Health Solutions
Speaker: Tarek A. Hammad, MD, PhD, MSc, MS, FISPE – Takeda
Speaker: Juhaeri Juhaeri, PhD – Epidemiology & Benefit - Risk Evaluation, Sanofi
Speaker: Bennett S. Levitan, MD-PhD – Janssen Pharmaceuticals
Speaker: Carol Mansfield, PhD – RTI Health Solutions
Lead Speaker: Jacqueline G. Hugtenburg – University of Curacao and VU University Medical Center Amsterdam
Speaker: Julie Lauffenburger, PharmD, PhD – BWH Div of Pharmacoepidemiology and Pharmacoeconomics
Speaker: Robert Gross, MD, MSCE, FISPE – University of Pennsylvania
Lead Speaker: Petra Denig, PharmD, PhD, FISPE – University Medical Center Groningen
Speaker: Katja Taxis, MSc, PhD, FISPE – University of Groningen
Speaker: Mina Tadrous, PharmD, PhD, MS, FISPE – University of Toronto
Speaker: Lotte Rasmussen, MScPharm, PhD – Syddansk Universitet
Lead Speaker: Nivantha Naidoo, MBChB, DipPEC, MPH, MSc CER (she/her/hers) – Cerner Enviza an Oracle company
Moderator: Deborah Layton, PhD, FISPE – PEPI Consultancy Limited
Speaker: Samantha Lane, MSc, PgD (she/her/hers) – Institute of Pharmacovigilance Sciences, Drug Safety Research Unit
Speaker: Tzuyung Douglas Kou, PhD, MPH, MA. (he/him/his) – BeiGene USA, Inc.
Lead Speaker: Sebastian Schneeweiss, MD, ScD, FISPE (he/him/his) – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA
Speaker: Jeremy A. Rassen, ScD, FISPE – Aetion
Speaker: Richard Wyss, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston, MA
Speaker: Elizabeth M. Garry, MPH, PhD – Aetion, Inc.
Lead Speaker: Geetha Iyer, MBBS, SM, PhD – Harvard School of Public Health
Speaker: Joshua J. Gagne, PharmD, ScD, FISPE – Johnson & Johnson
Lead Speaker: Harriet Dickinson, MPhil, PhD – Gilead
Lead Speaker: Dana Y. Teltsch, PhD, MSc – Takeda
Speaker: Victoria Y. Strauss, PhD – Boehringer Ingelheim Pharma GmbH & Co. KG
Speaker: Orla M. Doyle, PhD, BEng – Novartis
Speaker: Kathryn Rough, ScD, ScM (she/her/hers) – IQVIA
Lead Speaker: Mary Beth E. Ritchey, PhD, FISPE – Food and Drug Administration
Speaker: Christina Mack, PhD, MSPH, FISPE (she/her/hers) – IQVIA
Speaker: Mackenzie M. Herzog, PhD, MPH (she/her/hers) – IQVIA
Speaker: David Maislin – Biomedical Statistical Consulting
Speaker: Paul M. Coplan, ScD, MBA, FISPE – Office of the Chief Medical Officer, Johnson & Johnson
Lead Speaker: Nancy A. Dreyer, PhD, MPH, FISPE, Fellow DIA (she/her/hers) – Dreyer Strategies LLC
Speaker: Christina Mack, PhD, MSPH, FISPE (she/her/hers) – IQVIA
Speaker: William G. Dixon, MD PhD – The University of Manchester
Speaker: Nabarun Dasgupta, MPH, PhD – UNC Injury Prevention Research Center, University of North Carolina, Chapel Hill, NC, USA
Lead Speaker: Miguel A. Hernan – CAUSALab, Harvard T.H. Chan School of Public Health
Moderator: Deborah Layton, PhD, FISPE – PEPI Consultancy Limited
Speaker: Xabier Garcia de Albeniz Martinez, MD, ScM, PhD – RTI Health Solutions
Lead Speaker: Jaclyn L. Bosco, PhD, MPH. FISPE – IQVIA
Speaker: Rohini K. Hernandez, PhD MPH (she/her/hers) – Amgen, Inc.
Speaker: Ylenia Ingrasciotta, PhD – Department of Diagnostics and Public Health, University of Verona, Verona
Speaker: Hui-Lee Wong, PhD (she/her/hers) – US Food and Drug Administration
Lead Speaker: Jennifer Gerber, PhD, MSc – GlaxoSmithKline
Speaker: Morgan Marks, PhD (he/him/his) – Infectious Disease Epidemiology, Moderna Therapeutics Inc.
Speaker: Henok Tadesse Ayele, PhD – Merck & Co., Inc.
Speaker: Hector S. Izurieta, MD, MPH, PhD – Office of Vaccines Research and Review, CBER/FDA
Speaker: Robert T. Chen, MA, MD, FISPE – Brighton Collaboration
Speaker: Joanne Wu, ScD (she/her/hers) – Pfizer Inc
Speaker: Cindy Ke Zhou, PhD, MBBS (she/her/hers) – Moderna, Inc
Speaker: Deshayne B. Fell – University of Ottawa
Speaker: Annette Regan, PhD, MPH (she/her/hers) – University of San Francisco, San Francisco CA, USA
Speaker: Leah J. McGrath, PhD – Pfizer
Speaker: Christopher G. Prener, PhD – Pfizer, Inc
Lead Speaker: Andrea V. Margulis, MD ScD FISPE – RTI Health Solutions
Speaker: Brian T. Bateman, MD, MSc – Department of Anesthesiology, Perioperative and Pain Medicine, Department of Epidemiology and Population Health, Stanford University School of Medicine
Speaker: Sonia Hernandez-Diaz, MD, DPH, FISPE – Harvard University
Speaker: Krista F. Huybrechts, MS, PhD, FISPE – Brigham and Women's Hospital, Harvard Medical School
Lead Speaker: Katsiaryna Bykov, PharmD, ScD – Brigham and Women's Hospital and Harvard Medical School
Speaker: Todd Miano, PharmD, PhD – Perelman School of Medicine at the University of Pennsylvania
Speaker: Antonios Douros, MD (he/him/his) – Institute of Clinical Pharmacology and Toxicology, Charité
Lead Speaker: Judith C. Maro, PhD (she/her/hers) – Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School
Lead Speaker: Monica A. Munoz, PharmD, PhD (she/her/hers) – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration
Speaker: G. Niklas Norén, PhD – Uppsala Monitoring Centre
Speaker: Greg Powell, PharmD, MBA (he/him/his) – GlaxoSmithKline
Lead Speaker: Priya Bahri, PhD, PGDipEpi, RPh, FISoP – European Medicines Agency
Lead Speaker: Meredith Y. Smith, PhD, MPA, FISPE – Evidera, Inc
Speaker: Peter GM Mol, PhD PharmD – Dutch Medicines Evaluation Board
Speaker: Elaine Morrato, DrPH, MPH, FISPE – Loyola University Chicago
Speaker: Amir Sarayani, PhD, PharmD, MPH (he/him/his) – Janssen Research & Development, Johnson & Johnson
Speaker: Rania Mouchantaf, PhD (she/her/hers) – Health Canada
Speaker: Almut G. Winterstein, PhD, FISPE – University of Florida, Pharmaceutical Outcomes & Policy, Center for Drug Evaluation & Safety